These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 9008160)
1. p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Carpino N; Wisniewski D; Strife A; Marshak D; Kobayashi R; Stillman B; Clarkson B Cell; 1997 Jan; 88(2):197-204. PubMed ID: 9008160 [TBL] [Abstract][Full Text] [Related]
2. c-kit ligand stimulates tyrosine phosphorylation of a similar pattern of phosphotyrosyl proteins in primary primitive normal hematopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemia. Wisniewski D; Strife A; Berman E; Clarkson B Leukemia; 1996 Feb; 10(2):229-37. PubMed ID: 8637231 [TBL] [Abstract][Full Text] [Related]
3. Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins. Di Cristofano A; Carpino N; Dunant N; Friedland G; Kobayashi R; Strife A; Wisniewski D; Clarkson B; Pandolfi PP; Resh MD J Biol Chem; 1998 Feb; 273(9):4827-30. PubMed ID: 9478921 [TBL] [Abstract][Full Text] [Related]
4. Tyrosine phosphorylation of p62dok by p210bcr-abl inhibits RasGAP activity. Kashige N; Carpino N; Kobayashi R Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2093-8. PubMed ID: 10688886 [TBL] [Abstract][Full Text] [Related]
5. Interactions of p62(dok) with p210(bcr-abl) and Bcr-Abl-associated proteins. Bhat A; Johnson KJ; Oda T; Corbin AS; Druker BJ J Biol Chem; 1998 Nov; 273(48):32360-8. PubMed ID: 9822717 [TBL] [Abstract][Full Text] [Related]
7. p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl). Di Cristofano A; Niki M; Zhao M; Karnell FG; Clarkson B; Pear WS; Van Aelst L; Pandolfi PP J Exp Med; 2001 Aug; 194(3):275-84. PubMed ID: 11489947 [TBL] [Abstract][Full Text] [Related]
8. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells. Wisniewski D; Strife A; Swendeman S; Erdjument-Bromage H; Geromanos S; Kavanaugh WM; Tempst P; Clarkson B Blood; 1999 Apr; 93(8):2707-20. PubMed ID: 10194451 [TBL] [Abstract][Full Text] [Related]
9. Role of Dok-1 and Dok-2 in leukemia suppression. Niki M; Di Cristofano A; Zhao M; Honda H; Hirai H; Van Aelst L; Cordon-Cardo C; Pandolfi PP J Exp Med; 2004 Dec; 200(12):1689-95. PubMed ID: 15611295 [TBL] [Abstract][Full Text] [Related]
10. Insulin receptor-mediated p62dok tyrosine phosphorylation at residues 362 and 398 plays distinct roles for binding GTPase-activating protein and Nck and is essential for inhibiting insulin-stimulated activation of Ras and Akt. Wick MJ; Dong LQ; Hu D; Langlais P; Liu F J Biol Chem; 2001 Nov; 276(46):42843-50. PubMed ID: 11551902 [TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol 3-kinase and Src family kinases are required for phosphorylation and membrane recruitment of Dok-1 in c-Kit signaling. Liang X; Wisniewski D; Strife A; Shivakrupa ; Clarkson B; Resh MD J Biol Chem; 2002 Apr; 277(16):13732-8. PubMed ID: 11825908 [TBL] [Abstract][Full Text] [Related]
12. Downstream of kinase, p62(dok), is a mediator of Fc gamma IIB inhibition of Fc epsilon RI signaling. Ott VL; Tamir I; Niki M; Pandolfi PP; Cambier JC J Immunol; 2002 May; 168(9):4430-9. PubMed ID: 11970986 [TBL] [Abstract][Full Text] [Related]
13. New understanding of the pathogenesis of CML: a prototype of early neoplasia. Clarkson BD; Strife A; Wisniewski D; Lambek C; Carpino N Leukemia; 1997 Sep; 11(9):1404-28. PubMed ID: 9305592 [TBL] [Abstract][Full Text] [Related]
14. Characterization of a novel member of the DOK family that binds and modulates Abl signaling. Cong F; Yuan B; Goff SP Mol Cell Biol; 1999 Dec; 19(12):8314-25. PubMed ID: 10567556 [TBL] [Abstract][Full Text] [Related]
15. Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia. Yasuda T; Shirakata M; Iwama A; Ishii A; Ebihara Y; Osawa M; Honda K; Shinohara H; Sudo K; Tsuji K; Nakauchi H; Iwakura Y; Hirai H; Oda H; Yamamoto T; Yamanashi Y J Exp Med; 2004 Dec; 200(12):1681-7. PubMed ID: 15611294 [TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein. Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K Exp Hematol; 1995 Oct; 23(11):1153-9. PubMed ID: 7556524 [TBL] [Abstract][Full Text] [Related]
17. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. Carlesso N; Frank DA; Griffin JD J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285 [TBL] [Abstract][Full Text] [Related]
18. Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells. Nichols GL; Raines MA; Vera JC; Lacomis L; Tempst P; Golde DW Blood; 1994 Nov; 84(9):2912-8. PubMed ID: 7524758 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line. Matulonis U; Salgia R; Okuda K; Druker B; Griffin JD Exp Hematol; 1993 Oct; 21(11):1460-6. PubMed ID: 8405226 [TBL] [Abstract][Full Text] [Related]
20. Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok. Yamanashi Y; Baltimore D Cell; 1997 Jan; 88(2):205-11. PubMed ID: 9008161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]